Hamilton Thomas Edward 4
4 · Larimar Therapeutics, Inc. · Filed Jun 30, 2020
Insider Transaction Report
Form 4
Hamilton Thomas Edward
Director
Transactions
- Other
Common Stock
2020-06-26+159,433→ 292,853 total(indirect: FA Life Sciences, Inc.) - Other
Common Stock
2020-06-26+133,420→ 133,420 total
Footnotes (2)
- [F1]Pro rata distribution from Chondrial Therapeutics Holdings, LLC ("Holdings") to its members, for no consideration. The reporting person is a member of the board of managers of Holdings.
- [F2]Pro rata distribution from Holdings to its members, for no consideration.